Cargando…
Toll-like receptor 4 (TLR4): new insight immune and aging
TLR4, a transmembrane receptor, plays a central role in the innate immune response. TLR4 not only engages with exogenous ligands at the cellular membrane’s surface but also interacts with intracellular ligands, initiating intricate intracellular signaling cascades. Through MyD88, an adaptor protein,...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668412/ https://www.ncbi.nlm.nih.gov/pubmed/38001481 http://dx.doi.org/10.1186/s12979-023-00383-3 |
_version_ | 1785149125116821504 |
---|---|
author | Kim, Hyo-Jin Kim, Hyemin Lee, Jeong-Hyung Hwangbo, Cheol |
author_facet | Kim, Hyo-Jin Kim, Hyemin Lee, Jeong-Hyung Hwangbo, Cheol |
author_sort | Kim, Hyo-Jin |
collection | PubMed |
description | TLR4, a transmembrane receptor, plays a central role in the innate immune response. TLR4 not only engages with exogenous ligands at the cellular membrane’s surface but also interacts with intracellular ligands, initiating intricate intracellular signaling cascades. Through MyD88, an adaptor protein, TLR4 activates transcription factors NF-κB and AP-1, thereby facilitating the upregulation of pro-inflammatory cytokines. Another adapter protein linked to TLR4, known as TRIF, autonomously propagates signaling pathways, resulting in heightened interferon expression. Recently, TLR4 has garnered attention as a significant factor in the regulation of symptoms in aging-related disorders. The persistent inflammatory response triggered by TLR4 contributes to the onset and exacerbation of these disorders. In addition, alterations in TLR4 expression levels play a pivotal role in modifying the manifestations of age-related diseases. In this review, we aim to consolidate the impact of TLR4 on cellular senescence and aging-related ailments, highlighting the potential of TLR4 as a novel therapeutic target that extends beyond immune responses. |
format | Online Article Text |
id | pubmed-10668412 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106684122023-11-24 Toll-like receptor 4 (TLR4): new insight immune and aging Kim, Hyo-Jin Kim, Hyemin Lee, Jeong-Hyung Hwangbo, Cheol Immun Ageing Review TLR4, a transmembrane receptor, plays a central role in the innate immune response. TLR4 not only engages with exogenous ligands at the cellular membrane’s surface but also interacts with intracellular ligands, initiating intricate intracellular signaling cascades. Through MyD88, an adaptor protein, TLR4 activates transcription factors NF-κB and AP-1, thereby facilitating the upregulation of pro-inflammatory cytokines. Another adapter protein linked to TLR4, known as TRIF, autonomously propagates signaling pathways, resulting in heightened interferon expression. Recently, TLR4 has garnered attention as a significant factor in the regulation of symptoms in aging-related disorders. The persistent inflammatory response triggered by TLR4 contributes to the onset and exacerbation of these disorders. In addition, alterations in TLR4 expression levels play a pivotal role in modifying the manifestations of age-related diseases. In this review, we aim to consolidate the impact of TLR4 on cellular senescence and aging-related ailments, highlighting the potential of TLR4 as a novel therapeutic target that extends beyond immune responses. BioMed Central 2023-11-24 /pmc/articles/PMC10668412/ /pubmed/38001481 http://dx.doi.org/10.1186/s12979-023-00383-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Kim, Hyo-Jin Kim, Hyemin Lee, Jeong-Hyung Hwangbo, Cheol Toll-like receptor 4 (TLR4): new insight immune and aging |
title | Toll-like receptor 4 (TLR4): new insight immune and aging |
title_full | Toll-like receptor 4 (TLR4): new insight immune and aging |
title_fullStr | Toll-like receptor 4 (TLR4): new insight immune and aging |
title_full_unstemmed | Toll-like receptor 4 (TLR4): new insight immune and aging |
title_short | Toll-like receptor 4 (TLR4): new insight immune and aging |
title_sort | toll-like receptor 4 (tlr4): new insight immune and aging |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668412/ https://www.ncbi.nlm.nih.gov/pubmed/38001481 http://dx.doi.org/10.1186/s12979-023-00383-3 |
work_keys_str_mv | AT kimhyojin tolllikereceptor4tlr4newinsightimmuneandaging AT kimhyemin tolllikereceptor4tlr4newinsightimmuneandaging AT leejeonghyung tolllikereceptor4tlr4newinsightimmuneandaging AT hwangbocheol tolllikereceptor4tlr4newinsightimmuneandaging |